Ajinomoto Group ASV Report 2025 Overview

The document is an ASV Report for the year 2025, detailing the Ajinomoto Group's strategic initiatives and growth areas. It outlines the company's commitment to advancing healthcare, food and wellness, information and communication technology (ICT), and sustainability through its 'AminoScience' approach. The report emphasizes the integration of innovative business models and the establishment of a cell therapy value chain in the healthcare sector, particularly through the acquisition of Forge Biologics. It also discusses the anticipated growth in gene therapy and the company's efforts to address social issues while enhancing corporate value. Furthermore, the report highlights the transformation of the food and wellness sector towards nutrition and sustainability, alongside the implementation of the POND concept to improve customer engagement and adapt to changing market dynamics. Overall, the document presents a comprehensive view of the Ajinomoto Group's vision for future growth and social contribution.